Managing Director & Partner
Mills Schenck is head of Boston Consulting Group's Nairobi office. He is a core member of BCG's Corporate Finance & Strategy (CFS) practice area, and has deep experience in corporate strategy, covering growth, portfolio, M&A, and investor strategy across a range of industries including health care, financial services, and consumer goods.
Mills has advised multiple Kenya-based companies on strategy development and planning, incorporating global best practices and local market dynamics to drive value creation. He also has experience supporting non-profit organizations and large-scale donors on global health and development strategies in East Africa.
Prior to joining BCG, Mills worked in Visa USA's corporate development group and at Harris Williams & Co., a boutique investment bank.
In this video, Mills Schenck, Managing Director and Partner, articulates how BCG partners across clients and sectors to help address some of the world’s biggest challenges.
To combat climate change in Africa effectively, investors, governments, and companies must collaboratively develop and finance sustainability-driven ventures that can grow rapidly across the continent’s business ecosystem.
WFP and BCG estimate that the 70% increase in Kenyan fertilizer prices will reduce 2022 maize yields by 12%, which reflects the annual maize consumption of 4-5 million Kenyans.
Although the pandemic has highlighted persistent gaps in Africa’s healthcare systems and their international dependencies, there are promising hints that healthcare entrepreneurship is beginning to find a serious footing on the continent.
Since 2019, BCG has partnered with Teach for Uganda, part of Teach for All's global network of independent organizations focused on expanding educational opportunity.
The report shares key findings on COVID-19 impact and response on the ground in urban areas of Kenya and Uganda.
African governments must develop a response that is comprehensive, adaptive, and implemented effectively in order to take fast action in several areas.
BCG’s second global benchmarking study finds that the industry has made limited progress in fixing its commercial model. Yet firms that take action are posting strong shareholder returns.
As US hospital systems consolidate, medtech companies that develop a top-quality KAM function will build a powerful advantage in the near and longer terms.